Concepedia

Varsha Gandhi

VG

Statistics

Publications

211

Citations

16.3K

H-Index

64

Active since

1982

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Varsha Gandhi is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacology, medicine, and oncology.

ORCID

Publications per year

1982–2024

211

Publications

211

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren A. Byers, Lixia Diao, Jing Wang et al. · Clinical Cancer Research · 2012 · 1.1K citations · Full text

, , +17

Gemcitabine: metabolism, mechanisms of action, and self-potentiation.

William Plunkett, Peng Huang, Yi-Zheng Xu et al. · PubMed · 1995 · 756 citations

, , +6

The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo

Sabine Ponader, Shih‐Shih Chen, Joseph J. Buggy et al. · Blood · 2011 · 635 citations · Full text

, , +15

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · New England Journal of Medicine · 2019 · 504 citations · Full text

, , +17

Gemcitabine: preclinical pharmacology and mechanisms of action.

William Plunkett, Peng Huang, C. E. Searcy et al. · PubMed · 1996 · 395 citations

, , +7

1–5 of 211